Half Year 2025 EssilorLuxottica SA Earnings Call Transcript
Key Points
- Essilorluxottica (ESLOF) reported a revenue growth of 7.3% at constant currency, showcasing solid momentum across both quarters.
- The company is making significant strides in the medtech space with strategic acquisitions like Optegra high clinics, enhancing its eyecare offerings.
- Ray-Ban Meta sales grew more than 200% year over year, demonstrating strong market acceptance and growth potential.
- Essilorluxottica (ESLOF) has been recognized by Time Magazine as one of the 100 most influential companies of 2025 in the category of innovators.
- The company is expanding its product portfolio with innovative launches like Oakley Meta AI glasses and Essilor Stellest 2.0 lenses, addressing diverse consumer needs.
- The company faced a 4 percentage point difference between constant and current exchange results due to the devaluation of the US dollar against the euro.
- Essilorluxottica (ESLOF) experienced a gross margin dilution of 80 basis points at constant currency, primarily due to tariffs and the rapid growth of Ray-Ban Meta.
- The North American market saw negative growth in department stores and e-commerce partners during Q2.
- Despite revenue growth, the company's net income was down 10 basis points at constant currency, indicating pressure on profitability.
- The company continues to face material inflationary headwinds and volatility related to US tariffs, impacting financial performance.
Good morning and good afternoon, everybody. This is Giorgio Iannella from the IR team. Thank you for joining EssilorLuxottica interim results management call. The Group's Chairman and CEO, Francesco Milleri; the Deputy CEO, Paul du Saillant; and the CFO, Stefano Grassi, will walk you through the business and financial highlights of the first half of the year. (Operator Instructions)
With that, I hand it over to Francesco.
Welcome everyone. I'm pleased to reconnect with you to share our first half financial results and update you on our progress in medtech and wearable.
Let's begin with our long-term vision. We believe the future of glasses goes far beyond vision correction. They will become innovative, powerful, AI-enabled platforms that support human performance and healthcare at various levels. Thanks to our unique scale, capability, and global reach, we are in a position to lead this
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
